212 related articles for article (PubMed ID: 22035702)
1. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
Bini EJ; Kritz S; Brown LS; Robinson J; Calsyn D; Alderson D; Tracy K; McAuliffe P; Smith C; Rotrosen J
J Subst Abuse Treat; 2012 Jun; 42(4):438-45. PubMed ID: 22035702
[TBL] [Abstract][Full Text] [Related]
2. Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program.
Felsen UR; Fishbein DA; Litwin AH
J Addict Dis; 2010 Oct; 29(4):461-5. PubMed ID: 20924882
[TBL] [Abstract][Full Text] [Related]
3. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia.
Winstock AR; Anderson CM; Sheridan J
Med J Aust; 2006 Jun; 184(11):560-2. PubMed ID: 16768662
[TBL] [Abstract][Full Text] [Related]
4. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
Kramer JR; Hachem CY; Kanwal F; Mei M; El-Serag HB
Hepatology; 2011 Jan; 53(1):42-52. PubMed ID: 21254161
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
Frimpong JA; D'Aunno T; Jiang L
Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
[TBL] [Abstract][Full Text] [Related]
6. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
7. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
Astone JM; Strauss SM; Hagan H; Des Jarlais DC
Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
[TBL] [Abstract][Full Text] [Related]
8. Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.
Brown LS; Kritz S; Goldsmith RJ; Bini EJ; Robinson J; Alderson D; Rotrosen J
Public Health Rep; 2007; 122(4):441-51. PubMed ID: 17639646
[TBL] [Abstract][Full Text] [Related]
9. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.
Lamden KH; Kennedy N; Beeching NJ; Lowe D; Morrison CL; Mallinson H; Mutton KJ; Syed Q
J Infect; 1998 Nov; 37(3):260-9. PubMed ID: 9892530
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
[TBL] [Abstract][Full Text] [Related]
14. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
Rance J; Newland J; Hopwood M; Treloar C
Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
[TBL] [Abstract][Full Text] [Related]
15. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
16. Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014.
Ward JW
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):1-4. PubMed ID: 27168654
[No Abstract] [Full Text] [Related]
17. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection.
Perumalswami PV; Bini EJ
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):145-55. PubMed ID: 16557186
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
[TBL] [Abstract][Full Text] [Related]
20. Gaps in the drug-free and methadone treatment program response to Hepatitis C.
Strauss SM; Astone J; Vassilev ZP; Des Jarlais DC; Hagan H
J Subst Abuse Treat; 2003 Jun; 24(4):291-7. PubMed ID: 12867202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
